Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 17

1.

Bilateral Tactile Feedback-Enabled Training for Stroke Survivors Using Microsoft KinectTM.

Orand A, Erdal Aksoy E, Miyasaka H, Weeks Levy C, Zhang X, Menon C.

Sensors (Basel). 2019 Aug 8;19(16). pii: E3474. doi: 10.3390/s19163474.

2.

Development of a recombinant tetravalent dengue virus vaccine: immunogenicity and efficacy studies in mice and monkeys.

Clements DE, Coller BA, Lieberman MM, Ogata S, Wang G, Harada KE, Putnak JR, Ivy JM, McDonell M, Bignami GS, Peters ID, Leung J, Weeks-Levy C, Nakano ET, Humphreys T.

Vaccine. 2010 Mar 24;28(15):2705-15. doi: 10.1016/j.vaccine.2010.01.022. Epub 2010 Jan 22.

3.

Oral and parenteral immunization of chickens (Gallus gallus) against West Nile virus with recombinant envelope protein.

Fassbinder-Orth CA, Hofmeister EK, Weeks-Levy C, Karasov WH.

Avian Dis. 2009 Dec;53(4):502-9.

PMID:
20095149
4.

Immunogenicity and protective efficacy of a recombinant subunit West Nile virus vaccine in rhesus monkeys.

Lieberman MM, Nerurkar VR, Luo H, Cropp B, Carrion R Jr, de la Garza M, Coller BA, Clements D, Ogata S, Wong T, Martyak T, Weeks-Levy C.

Clin Vaccine Immunol. 2009 Sep;16(9):1332-7. doi: 10.1128/CVI.00119-09. Epub 2009 Jul 29.

5.

Evaluation of the efficacy of a recombinant subunit West Nile vaccine in Syrian golden hamsters.

Siirin MT, Travassos da Rosa AP, Newman P, Weeks-Levy C, Coller BA, Xiao SY, Lieberman MM, Watts DM.

Am J Trop Med Hyg. 2008 Dec;79(6):955-62.

6.

Protective efficacy of a recombinant subunit West Nile virus vaccine in domestic geese (Anser anser).

Jarvi SI, Lieberman MM, Hofmeister E, Nerurkar VR, Wong T, Weeks-Levy C.

Vaccine. 2008 Oct 3;26(42):5338-44. doi: 10.1016/j.vaccine.2008.08.011. Epub 2008 Aug 22.

PMID:
18723064
7.

Efficacy and durability of a recombinant subunit West Nile vaccine candidate in protecting hamsters from West Nile encephalitis.

Watts DM, Tesh RB, Siirin M, Rosa AT, Newman PC, Clements DE, Ogata S, Coller BA, Weeks-Levy C, Lieberman MM.

Vaccine. 2007 Apr 12;25(15):2913-8. Epub 2006 Aug 22.

8.

Preparation and immunogenic properties of a recombinant West Nile subunit vaccine.

Lieberman MM, Clements DE, Ogata S, Wang G, Corpuz G, Wong T, Martyak T, Gilson L, Coller BA, Leung J, Watts DM, Tesh RB, Siirin M, Travassos da Rosa A, Humphreys T, Weeks-Levy C.

Vaccine. 2007 Jan 5;25(3):414-23. Epub 2006 Aug 30.

9.

Characterization of mouse lines transgenic with the human poliovirus receptor gene.

Deatly AM, Taffs RE, McAuliffe JM, Nawoschik SP, Coleman JW, McMullen G, Weeks-Levy C, Johnson AJ, Racaniello VR.

Microb Pathog. 1998 Jul;25(1):43-54.

PMID:
9705248
10.

Characterization of recombinant polioviruses expressing regions of rotavirus VP4, hepatitis B surface antigen, and herpes simplex virus type 2 glycoprotein D.

Mattion NM, Reilly PA, Camposano E, Wu SL, DiMichele SJ, Ishizaka ST, Fantini SE, Crowley JC, Weeks-Levy C.

J Virol. 1995 Aug;69(8):5132-7.

11.

Attenuated temperature-sensitive respiratory syncytial virus mutants generated by cold adaptation.

Randolph VB, Kandis M, Stemler-Higgins P, Kennelly MS, McMullen YM, Speelman DJ, Weeks-Levy C.

Virus Res. 1994 Sep;33(3):241-59.

PMID:
7985411
12.
13.

Significance of a newly identified attenuating mutation in Sabin 3 oral poliovirus vaccine.

Mento SJ, Weeks-Levy C, Tatem JM, Gorgacz EJ, Waterfield WF.

Dev Biol Stand. 1993;78:93-9; discussion 99-100.

PMID:
8388835
14.

A mutation present in the amino terminus of Sabin 3 poliovirus VP1 protein is attenuating.

Tatem JM, Weeks-Levy C, Georgiu A, DiMichele SJ, Gorgacz EJ, Racaniello VR, Cano FR, Mento SJ.

J Virol. 1992 May;66(5):3194-7.

15.

Identification and characterization of a new base substitution in the vaccine strain of Sabin 3 poliovirus.

Weeks-Levy C, Tatem JM, DiMichele SJ, Waterfield W, Georgiu AF, Mento SJ.

Virology. 1991 Dec;185(2):934-7. Erratum in: Virology 1992 Apr;187(2):845.

PMID:
1660210
16.

Oral poliovirus vaccine in the United States: molecular characterization of Sabin type 3 after replication in the gut of vaccinees.

Tatem JM, Weeks-Levy C, Mento SJ, DiMichele SJ, Georgiu A, Waterfield WF, Sheip B, Costalas C, Davies T, Ritchey MB, et al.

J Med Virol. 1991 Oct;35(2):101-9.

PMID:
1662701
17.

Characterization of Vero cells.

Swanson SK, Mento SJ, Weeks-Levy C, Brock BD, Kowal KJ, Wallace RE, Ritchey MB, Cano FR.

J Biol Stand. 1988 Oct;16(4):311-20.

PMID:
3198660

Supplemental Content

Loading ...
Support Center